Development of Bortezomib Induced Peripheral Neuropathy (BiPN) In Multiple Myeloma: Incidence and Molecular Characterization In Newly Diagnosed Patients Treated with Bortezomib

被引：0
|
作者：
Broyl, Annemiek [1 ]
Corthals, Sophie [1 ]
Jongen, Joost L. M. [1 ]
van der Holt, Bronno [1 ]
Kuiper, Rowan [1 ]
de Knegt, Yvonne [1 ]
el Jarari, Laila [1 ]
Bertsch, Uta [2 ]
Lokhorst, Henk [3 ]
Durie, Brian G. M. [4 ]
Goldschmidt, Hartmut [2 ]
Sonneveld, Pieter [5 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Klinikum, Med Klin 5, Heidelberg, Germany
[3] Univ Med Ctr, Utrecht, Netherlands
[4] Aptium Oncol Inc, Rsch Network, Los Angeles, CA USA
[5] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)
    Muslimani, Ala'a
    Moore, Donald C.
    Ringley, Tanner
    Robinson, Myra M.
    BLOOD, 2018, 132
  • [2] Generic Bortezomib-induced Severe Peripheral Neuropathy in Newly Diagnosed Multiple Myeloma Patients
    Chakrabarti, P.
    Chaudhuri, U.
    Nath, U.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S86 - S87
  • [3] Impact of Body Mass Index on the Incidence of Bortezomib-induced Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma
    Moore, Donald C.
    Ringley, J. Tanner
    Nix, David
    Muslimani, Ala'a
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (03): : 168 - 173
  • [4] Feasibility of cryocompression for bortezomib-induced peripheral neuropathy (BIPN) among patients with multiple myeloma (MM).
    Statler, Tiffany M.
    Hsu, Fang-Chi
    Lambird, Jonathan
    Hurd, David Duane
    Cartwright, Michael Stephen
    Mehta, Rachana Gandhi
    Crisp, James
    Strowd, Roy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma
    Merz, Maximillan
    Salwender, Hans-Juergen
    Haenel, Mathias
    Bertsch, Uta
    Kunz, Christina
    Hielscher, Thomas
    Blau, Igor W.
    Scheid, Christof
    Mai, Elias Karl
    Hose, Dirk
    Schurich, Baerbel
    Munder, Markus
    Brossart, Peter
    Gerecke, Christian
    Lindemann, Hans Walter
    Zeis, Matthias
    Weisel, Katja C.
    Duerig, Jan
    Goldschmidt, Hartmut
    BLOOD, 2015, 126 (23)
  • [6] General Aspects and Mechanisms of Peripheral Neuropathy Associated With Bortezomib in Patients With Newly Diagnosed Multiple Myeloma
    Broyl, Annemiek
    Jongen, Joost L. M.
    Sonneveld, Pieter
    SEMINARS IN HEMATOLOGY, 2012, 49 (03) : 249 - 257
  • [7] DEVELOPMENT OF PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA PATIENTS; INCIDENCE, MOLECULAR CHARACTERIZATION AND EFFECT ON RESPONSE IN BORTEZOMIB VS CONVENTIONAL TREATMENT
    Broyl, A.
    Corthals, S.
    De Knegt, Y.
    van der Holt, B.
    Goldschmidt, H.
    Lokhorst, H.
    Durie, B.
    Van Ness, B.
    Sonneveld, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 216 - 216
  • [8] Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma
    Berkowitz, Anne
    Walker, Suzanne
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (01) : 86 - 89
  • [9] BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA PATIENTS
    Lalayanni, C.
    Iskas, M.
    Antoniou, A.
    Voutiadou, G.
    Georgiadou, E.
    Marvaki, A.
    Apostolou, C.
    Vadikoliou, C.
    Mallouri, D.
    Kaloyannidis, P.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 615 - 616
  • [10] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    HAEMATOLOGICA, 2014, 99 (11)
12345